# Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)

> **NCT01713309** · PHASE2,PHASE3 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 59 (actual)

## Conditions studied

- Acute Respiratory Failure
- Critically Ill

## Interventions

- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT01713309
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** 1998-06
- **Final completion:** 1998-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2012-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01713309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01713309, "Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01713309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*